货号:A252480
同义名:
Mitochondrial division inhibitor 1
Mdivi-1选择性抑制线粒体分裂蛋白DRP1和线粒体分裂动力蛋白I(Dnm1),IC50约为1-10 µM。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Dynamin ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dynasore |
++
Dynamin1/2, IC50: ~15 μM |
98% | |||||||||||||||||
| Mdivi-1 | 99%+ | ||||||||||||||||||
| Hydroxy-Dynasore |
++++
DynI (brain), IC50: 0.38 μM DynI (rec), IC50: 2.3 μM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Mdivi-1, derivative of quinazolinone, is a selective inhibitor of mitochondrial division by targeting Dnm1 (dynamin-1) and DRP (dynamin-related protein). In mammalian cells (COS cell), mdivi-1 inhibits mitochondrial division with IC50 of 50 μM by specially inhibiting DRP1 activity, and in Hela cell, mdivi-1 impedes apoptosis early in the intrinsic pathway by attenuating Bak/Bax dependent MOMP (mitochondrial outer membrane permeabilization)[3]. It has been shown to reduce seizure activity and increase survival of KA-reduced mice intravenously injected of 20 mg/kg mdivi-1 by protecting mitochondrial morphology and attenuating cell death in the hippocampus[4]. In the study of ischemia reperfusion injury, mdivi-1 can protect against ischemia reperfusion injury of spinal cord neurons and mitochondrial dysfunction in vivo through activating BK channels dependently in SD rat which were treated with intravenous bolus of 1 mg/kg[5]. The function of mdivi-1 is also reflected in the protection of ischemic retina. Research has shown that mdivi-1 can reverse cell apoptosis caused by transient retinal ischemia and significantly increase the number and survival of retinal ganglia cells by approximately 54% in 3-month-old C57BL/6 mice (intraperitoneal injection, 50 mg/kg). In addition, mdivi-1 treatment did not affect the increase of Drp1 protein expression, but obviously down-regulate the expression of GFAP[6]. Multiple roles of mdivi-1, such as reduces animal blood pressure, alleviate traumatic brain injury induced brain damage[7], and protect against doxorubicin-induced cardiotoxicity, have confirmed by relevant experiments[8]. In general, mdivi-1 provides a new treatment for stroke, myocardial infarction and neurodegenerative diseases. |
| Concentration | Treated Time | Description | References | |
| HEK293 cells | 50 µM | overnight | Mdivi-1 was used to inhibit DRP1 and study the effect of GJA1-20k on mitochondrial fission. The results showed that GJA1-20k could induce mitochondrial fission through actin polymerization independently of DRP1. | Elife. 2021 Oct 5;10:e69207. |
| H460 and H1299 cells | 15 μM | 96 h | To inhibit mitophagy and evaluate its effect on cell viability after shUSP35 infection | Clin Transl Med. 2021 Apr;11(4):e390. |
| A172 glioma cells | 1, 5, and 10 μM | 2 h | To assess changes in mitochondrial length and pregnenolone (P5) concentration. Results showed that MDIVI-1 dose-dependently increased mitochondrial length and P5 concentration. | Cells. 2020 Oct 19;9(10):2323. |
| A172 glioma cells | 5 μM | 24 h | To evaluate the rhythmic changes in P5 and TSPO protein levels after chronic MDIVI-1 treatment. Results showed that MDIVI-1 treatment abolished the rhythmic variations of P5 and TSPO. | Cells. 2020 Oct 19;9(10):2323. |
| NIH3T3 cells | 10 μM | Mdivi-1 significantly reduced caffeine-induced autophagosome formation, indicating that Mdivi-1 inhibits autophagy by preventing mitochondrial fission. | Theranostics. 2018 Nov 10;8(20):5713-5730. | |
| NIH3T3 cells | 10 µM | Mdivi-1, a mitophagy inhibitor that prevents mitochondria fission, dramatically reduced the caffeine-induced autophagosome formation | Theranostics. 2018 Nov 10;8(20):5713-5730. | |
| primary cortical neurons | 50 μM | 1 h | Mdivi-1 significantly inhibited basal and maximal respiration, indicating its inhibitory effect on mitochondrial Complex I-dependent respiration. | Dev Cell. 2017 Mar 27;40(6):583-594.e6. |
| COS-7 cells | 50 μM | 1 h | Mdivi-1 significantly inhibited basal and maximal respiration, indicating its inhibitory effect on mitochondrial Complex I-dependent respiration. | Dev Cell. 2017 Mar 27;40(6):583-594.e6. |
| Drp1 KO MEFs | 50 μM | 16 min | Mdivi-1 inhibited maximal respiration, indicating its inhibitory effect on mitochondrial Complex I-dependent respiration, independent of Drp1. | Dev Cell. 2017 Mar 27;40(6):583-594.e6. |
| vascular endothelial cells (ECs) | 5 μM | Mdivi-1 reduced Aβ-induced apoptosis of ECs by inhibiting mitochondrial fission, indicating that Aβ-induced mitochondrial fission is essential for ECs apoptosis. | Aging Cell. 2025 Feb;24(2):e14374. | |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | UV-induced skin damage model | Intraperitoneal injection | 1.5 mg/kg | Once daily for 6 weeks | Mdivi-1 blocked the protective effect of caffeine on UV-induced skin damage, indicating that Mdivi-1 attenuates the protective effect of caffeine by inhibiting mitophagy. | Theranostics. 2018 Nov 10;8(20):5713-5730. |
| Mice | UV irradiation-induced skin damage model | Intraperitoneal injection | 1.5 mg/kg | Once daily for 6 weeks | Inhibited UV-induced skin damage | Theranostics. 2018 Nov 10;8(20):5713-5730. |
| Mice | APP/PS1 mice | Not specified | 50 mg/kg | Twice a week for 4 weeks | Mdivi-1 effectively attenuated bone blood vessels injury and bone formation in APP/PS1 mice, indicating that Aβ-induced mitochondrial fission plays a critical role in bone blood vessels injury. | Aging Cell. 2025 Feb;24(2):e14374. |
| Dose | Rat: 20 mg/kg[3] (i.p.), 1.25 mg/kg[4] Mice: 20 mg/kg[5] (i.p.), 50 mg/kg[1] (i.p.), 1.2 mg/kg[6] (i.v.) |
| Administration | i.p., i.v. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.83mL 0.57mL 0.28mL |
14.16mL 2.83mL 1.42mL |
28.31mL 5.66mL 2.83mL |
|
| CAS号 | 338967-87-6 |
| 分子式 | C15H10Cl2N2O2S |
| 分子量 | 353.22 |
| SMILES Code | O=C1N(C2=CC(OC)=C(Cl)C=C2Cl)C(S)=NC3=C1C=CC=C3 |
| MDL No. | MFCD00974506 |
| 别名 | Mitochondrial division inhibitor 1 |
| 运输 | 蓝冰 |
| InChI Key | NZJKEVWTYMOYOR-UHFFFAOYSA-N |
| Pubchem ID | 3825829 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 155 mg/mL(438.82 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1